Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
William Echavidre, Vincent Picco, Marc Faraggi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1053-1053
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2116-2116
Open Access | Times Cited: 115
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Francisco Branco, Joana Cunha, Maria Mendes, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16359-16394
Open Access | Times Cited: 15
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives
F Santoro, Francesco Merlino, Diego Brancaccio, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 259-259
Open Access | Times Cited: 1
Image‐guided diagnosis and treatment of glioblastoma
Yongning Bian, Yaling Wang, Xueqian Chen, et al.
View (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 22
Targeted Radionuclide Therapy in Glioblastoma
Xiaobin Zhao, Vivianne Jakobsson, Yucen Tao, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 31, pp. 40391-40410
Closed Access | Times Cited: 7
The potential of exosomes as a new therapeutic strategy for glioblastoma
Leonor Cunha Silva, Francisco Branco, Joana Cunha, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114460-114460
Open Access | Times Cited: 7
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy
Kristina Viktorsson, Thorsten Rieckmann, Maximilian Fleischmann, et al.
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1091-1109
Open Access | Times Cited: 12
Enhancing the angiogenesis and osteogenesis of low elastic modulus Ti-Nb-Zr-Sn alloy surface through grafting growth factors-containing gelatin nanoparticles
Chia-En Yeh, Wei‐Cheng Chen, Chiang‐Sang Chen, et al.
Surfaces and Interfaces (2024) Vol. 46, pp. 104136-104136
Closed Access | Times Cited: 4
Understanding the Role of Endothelial Cells in Glioblastoma: Mechanisms and Novel Treatments
Gabrielle Hovis, Neha Chandra, Nidhi Kejriwal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6118-6118
Open Access | Times Cited: 4
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach
Habibullah Dadgar, Narges Jokar, Reza Nemati, et al.
Frontiers in Nuclear Medicine (2023) Vol. 3
Open Access | Times Cited: 10
Interaction of integrin αvβ3 and fibronectin under fluid shear forces: implications for tumor cell adhesion and migration
Paimin Zhuo, Quhuan Li, Bishan Yang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Cell membrane sialome machinery and regulation of receptor tyrosine kinases in gliomas: The functional relevance and therapeutic perspectives
Patrycja Jastrząb, Halina Car, Przemysław Wielgat
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117921-117921
Closed Access
Matrix metallopeptidase 2-responsive curcumin-loaded nanoparticles-induced signal transducer and activator of transcription 3 inhibition suppresses glioblastoma multiforme growth via enhancing nuclear factor erythroid 2-related factor 2 activity
Fujie Jia, Yingpeng Peng, Xiaobing Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141998-141998
Open Access
Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy
Yuki Mizuno, Thanakrit Suebboonprathueng, Satoru Onoe, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Integrin targeted photodynamic therapy in patient‐derived glioblastoma spheroids
Miriam Roberto, Meedie Ali, Ivo Que, et al.
Photochemistry and Photobiology (2025)
Open Access
Liposome-mediated anticancer drug delivery strategies for advancing brain tumor therapy
Mohsen Rahmanian, Fatemeh Oroojalian, Prashant Kesharwani, et al.
European Polymer Journal (2025), pp. 114001-114001
Closed Access
Navigating the tumor landscape: VEGF, MicroRNAs, and the future of cancer treatment
K P Ameya, Parveen Usman, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2025) Vol. 1868, Iss. 2, pp. 195091-195091
Closed Access
Internalisation of RGD-Engineered Extracellular Vesicles by Glioblastoma Cells
Dovydas Gečys, Arūnas Kazlauskas, Emilija Gečytė, et al.
Biology (2022) Vol. 11, Iss. 10, pp. 1483-1483
Open Access | Times Cited: 16
Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know
Neetu Soni, Manish Ora, Amarnath Jena, et al.
American Journal of Neuroradiology (2023) Vol. 44, Iss. 3, pp. 236-246
Open Access | Times Cited: 8
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
William Echavidre, Daniel Fagret, Marc Faraggi, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4839-4839
Open Access | Times Cited: 8
Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine
Cláudia Martins, Bruno Sarmento
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 6
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
Cibele Rodrigues Toledo, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8553-8553
Open Access | Times Cited: 2
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
William Echavidre, Jérôme Durivault, Célia Gotorbe, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 12, pp. 2483-2496
Open Access | Times Cited: 4
A comparison study of dynamic [18F]Alfatide II imaging and [11C]MET in orthotopic rat models of glioblastoma
Yue Pan, Haodan Dang, Haoxi Zhou, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 1
Repurposing gemcitabine for glioblastoma treatment: The role of drug-conjugates and nanoparticles as drug delivery systems
Maria João Ramalho, E.T. Serra, Joana A. Loureiro, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105714-105714
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top